Skip to main content
SpringerLink
Log in

Ondansetron a good choice among front-line antiemetics for children undergoing chemotherapy, radiotherapy and surgery

  • New Drugs and Profile Reports
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Culy CR, Bhana N, Plosker GL. Ondansetron: a review of its use as an antiemetic in children. Paediatr Drugs 2001; 3(6): 441–79

    Article  PubMed  CAS  Google Scholar 

  2. Roila F, Aapro M, Stewart A. Optimal selection of antiemetics in children receiving cancer chemotherapy. Support Care Cancer 1998 May; 6: 215–20

    Article  PubMed  CAS  Google Scholar 

  3. British National Formulary. 42nd ed. London: British Medical Association and Royal Pharmaceutical Society of GB, 2001 Sep

  4. Physicians’ Desk Reference. 55th ed. Montvale (NJ): Medical Economics Co. Inc, 2001

  5. 2001 Drug Topics Red Book. Montvale (NJ): Med Econ Co. Inc, 2001

  6. Kovac AL. Prevention and treatment of postoperative nausea and vomiting. Drugs 2000 Feb; 59(2): 213–43

    Article  PubMed  CAS  Google Scholar 

  7. Dick GS, Meller ST, Pinkerton CR. Randomised comparison of ondansetron and metoclopramide plus dexamethasone for chemotherapy induced emesis. Arch Dis Child 1995 Sep; 73: 243–5

    Article  PubMed  CAS  Google Scholar 

  8. Jimenez M, Leon P, Gimeno J, et al. Comparison of chlorpromazine plus dexamethasone vs ondansetron vs tropisetron in the treatment of emesis induced by highly and moderately emetogenic chemotherapy in pediatric patients with malignancies [abstract]. Med Pediatr Oncol 1997 Nov; 29: 496

    Google Scholar 

  9. Stiakaki E, Savvas S, Lydaki E. Ondansetron and tropisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy. Pediatr Hematol Oncol 1999 Mar–Apr; 16: 101–8

    Article  PubMed  CAS  Google Scholar 

  10. Tsuchida Y, Hayashi Y, Asami K, et al. Effects of granisetron in children undergoing high-dose chemotherapy: a multi-institutional, crossover study. Int J Oncol 1999 Apr; 14(4): 673–9

    PubMed  CAS  Google Scholar 

  11. Hahlen K, Quintana E, Pinkerton CR, et al. A randomized comparison of intravenously administered granisetron versus chlorpromazine plus dexamethasone in the prevention of ifosfamide-induced emesis in children. J Pediatr 1995 Feb; 126(2): 309–13

    Article  PubMed  CAS  Google Scholar 

  12. Yarker YE, McTavish D. Granisetron: an update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy. Drugs 1994; 48(5): 761–93

    Article  PubMed  CAS  Google Scholar 

  13. Komada Y, Matsuyama T, Takao A, et al. A randomised dose-comparison trial of granisetron in preventing emesis in children with leukaemia receiving emetogenic chemotherapy. Eur J Cancer 1999 Jul; 35(7): 1095–101

    Article  PubMed  CAS  Google Scholar 

  14. ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery. Am J Health System Pharm 1999 Apr 15; 56 (8): 729-64

  15. Köseoglu V, Kürekçi AE, Sorici Ü, et al. Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study. Eur J Pediatr 1998; 157(10): 806–10

    Article  PubMed  Google Scholar 

  16. Alvarez O, Freeman A, Bedros A, et al. Randomized double-blind crossover ondansetron-dexamethasone versus ondansetron-placebo study for the treatment of chemotherapy-induced nausea and vomiting in pediatric patients with malignancies. J Pediatr Hematol Oncol 1995 May; 17: 145–50

    Article  PubMed  CAS  Google Scholar 

  17. Tavorath R, Hesketh PJ. Drug treatment of chemotherapy-induced delayed emesis. Drugs 1996 Nov; 52(2): 639–48

    Article  PubMed  CAS  Google Scholar 

  18. Italian Group for Antiemetic Research. Prevention of cisplatin-induced delayed emesis. Support Care Cancer 2000 May; 8(3): 229–32

    Article  Google Scholar 

  19. Jürgens H, McQuade B. Ondansetron as prophylaxis for chemotherapy and radiotherapy-induced emesis in children. Oncology 1992; 49: 279–85

    Article  PubMed  Google Scholar 

  20. Hewitt M, Cornish J, Pamphilon D, et al. Effective emetic control during conditioning of children for bone marrow transplantation using ondansetron, a 5-HT3 antagonist. Bone Marrow Transplant 1991 Jun; 7: 431–3

    PubMed  CAS  Google Scholar 

  21. Nahata MC, Hui LN, Koepke J. Efficacy and safety of ondansetron in pediatric patients undergoing bone marrow transplantation. Clin Ther 1996 May–Jun; 18: 466–76

    Article  PubMed  CAS  Google Scholar 

  22. Mehta NH, Reed CM, Kuhlman C, et al. Controlling conditioning-related emesis in children undergoing bone marrow transplantation. Oncol Nurs Forum 1997 Oct; 24: 1539–44

    PubMed  CAS  Google Scholar 

  23. Orchard PJ, Rogosheske J, Burns L, et al. A prospective randomized trial of the anti-emetic efficacy of ondansetron and granisetron during bone marrow transplantation. Biol Blood Marrow Transplant 1999; 5: 386–93

    Article  PubMed  CAS  Google Scholar 

  24. Splinter WM, Rhine EJ. Low-dose ondansetron with dexamethasone more effectively decreases vomiting after strabismus surgery in children than does high-dose ondansetron. Anesthesiology 1998 Jan; 88: 72–5

    Article  PubMed  CAS  Google Scholar 

  25. Splinter WM, Rhine EJ, Roberts DJ, et al. Prevention of vomiting after strabismus surgery in children: dexamethasone alone vs dexamethasone plus low-dose ondansetron [abstract]. Anesth Analg 1998 Feb; 86 Suppl.: S419

    Article  Google Scholar 

  26. Finn AL. Toxicity and side effects of ondansetron. Semin Oncol 1992 Aug; 19(4 Suppl. 10): 53–60

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ondansetron a good choice among front-line antiemetics for children undergoing chemotherapy, radiotherapy and surgery. Drugs Ther. Perspect 18, 1–4 (2002). https://doi.org/10.2165/00042310-200218030-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200218030-00001

Keywords

Search

Navigation